Search Share Prices
AZN Headlines - AstraZeneca and Merck’s Lynparza drug approved by US FDA for pancreatic cancer
“Lynparza is now the only approved targeted medicine in biomarker-selected patients with advanced pancreatic cancer," said AstraZeneca's Dave Fredrickson. AstraZeneca Plc (LON:AZN) announced that the ...
Will these 3 FTSE 100 shares make 20% gains in 2020? Barclays, Taylor Wimpey and AstraZeneca
The performances of FTSE 100 shares Barclays PLC (LON:BARC) (BARC.L), Taylor Wimpey plc (LON:TW) (TW.L) and AstraZeneca plc (LON:AZN) (AZN.L) in 2019 has been strong. All three stocks have made gains ...
AstraZeneca and Daiichi Sankyo's breast cancer treatment gets US approval
AstraZeneca and Daiichi Sankyo are exploring the further potential of Enhertu in HER2-breast cancer with three ongoing Phase III trials The US Food and Drug Administration (FDA) has approved Enhertu, ...
AstraZeneca (LON:AZN) Earns “Overweight” Rating from Barclays
AstraZeneca (LON:AZN)‘s stock had its “overweight” rating reissued by stock analysts at Barclays in a report released on Friday, ThisIsMoney.Co.Uk reports. Several other equities analysts have also ...
AstraZeneca (LON:AZN) Given Buy Rating at Shore Capital
Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN) in a research note released on Wednesday morning, ThisIsMoney.Co.Uk reports. Several other brokerages have also issued ...